￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of discontinuation methods and safe discontinuation strategies of ritexitinib (Lefenox)

2026-02-01 22:25:32

Check Details
Analysis of the mechanism of action and clinical research progress of sparsentan

2026-02-01 22:25:32

Check Details
Contraindications of ixazomib (Enleri) and which groups should be cautious

2026-02-01 22:25:32

Check Details
Analysis on whether rubitin/rubicatin (Zanbiga) needs to be combined with other drug treatments

2026-02-01 22:25:32

Check Details
How to deal with missed doses of Pimitespib and safety remedies

2026-02-01 22:25:32

Check Details
What should I do if I miss a dose of Afatinib (Gyterinib)?

2026-02-01 22:25:32

Check Details
Summary of the clinical advantages and application of DaliRasheng (Keweike) in the treatment of insomnia

2026-02-01 22:25:32

Check Details
What are the dietary precautions and contraindications when taking Lynparza?

2026-02-01 22:25:32

Check Details
Regular purchasing channels and precautions for Laos generic drugs Venetoclax

2026-02-01 22:25:32

Check Details
Detailed instructions on discontinuation methods and precautions for Asnib/Asiminib

2026-02-01 22:25:32

Check Details
Things to note and operating guidelines while taking ritexitinib (Lefenox)

2026-02-01 22:25:32

Check Details
Whether sparsentan (sparsentan) needs to be taken continuously and the discontinuation plan

2026-02-01 22:25:32

Check Details
Category
相关知识